By
Latest Stories
Don’t miss our hot and upcoming stories
Can Bristol Myers Squibb and BioNTech’s $1.5B Bet on Bispecific Antibodies Disrupt PD1-VEGF Cancer Treatment Landscape?
Key Takeaways for Industry Leaders Strategic Shift: BMS Moves Deeper into Bispecific Immuno-OncologyIn a bold…
How GSK-Backed Onc.AI Is Using Deep Learning Radiomics to Disrupt Imaging Biomarkers in Biopharma Trials
Key Highlights: Reinventing RECIST: How Onc.AI’s Serial CTRS is Transforming Imaging BiomarkersOnc.AI is redefining how…
How Massive Bio’s AI is Unlocking Global Oncology Access for 3,800+ Cancer Patients Through ASCO25 Breakthroughs
Key Highlights: Revolutionizing Cancer Care With Multi-Agent AI at ASCO25Massive Bio is presenting its cutting-edge…
How 4D Molecular Therapeutics’ Innovative Gene Therapy Engine Is Revolutionizing Treatment for Retinal and Pulmonary Diseases
Key Highlights: 1. Accelerated Clinical Milestones for 4D-150 in Wet AMD and DME: 4DMT initiated…